Acertis Pharmaceuticals, LLC
4 drugs in NADAC|2 Generic,2 Brand
Acertis Pharmaceuticals, LLC lists 4 NDCs in the CMS NADAC file (2 generic, 2 brand), at an average NADAC of $15.08 per unit, with a week-over-week move of +0.4% across products that moved. The firm's full portfolio, pricing trend are listed below.
Total Drugs
4
2G / 2B
Avg Price / Unit
$15.0830
$3.38 – $30.39
Avg 7d Change
+0.37%
Across 3 drugs with changes
7d Activity
of 4 total drugs
Portfolio Price Trend
Monthly average NADAC price across all drugs
Keep following this manufacturer
These next-step links connect the manufacturer page to the markets, classes, and trend views most likely to deepen research.
Lead market
Progesterone market
See the molecule this manufacturer shows up in most often and compare it against competing suppliers.
Lead class
Progesterone therapeutic class
Review the broader class where Acertis Pharmaceuticals, LLC has the strongest current portfolio footprint.
Trend hub
Portfolio trend view
Jump to the trend hub to compare this manufacturer against the rest of the market on weekly price movement.
Guide
NADAC pricing primer
Use the explainer for context on the benchmark this manufacturer is being compared against.
Frequently Asked Questions
How many drugs does Acertis Pharmaceuticals, LLC make?
Acertis Pharmaceuticals, LLC lists 4 NDCs in the CMS NADAC file — 2 generic and 2 brand products.
What is the average price of Acertis Pharmaceuticals, LLC drugs?
The average NADAC across Acertis Pharmaceuticals, LLC's portfolio is $15.0830 per unit, ranging from $3.3821 to $30.3948.
What types of drugs does Acertis Pharmaceuticals, LLC make?
Acertis Pharmaceuticals, LLC makes drugs across 3 FDA pharmacologic classes. The most common by NDC count are Progesterone (2), Opioid Agonist (1), Sympathomimetic Amine Anorectic (1).
Has Acertis Pharmaceuticals, LLC had any drug recalls?
No FDA enforcement recalls are matched to Acertis Pharmaceuticals, LLC in the openFDA feed.
How has Acertis Pharmaceuticals, LLC's pricing changed recently?
Over the past 7 days, 1 Acertis Pharmaceuticals, LLC product rose and 2 fell, with a portfolio-wide average change of +0.4%.
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
PROMETRIUM 200 MG CAPSULE Progesterone | $30.3947 per EA | -0.07% |
PROMETRIUM 100 MG CAPSULE Progesterone | $15.9095 per EA | -0.07% |
LEVORPHANOL 2 MG TABLET Levorphanol Tartrate | $10.6456 per EA | — |
PHENDIMETRAZINE ER 105 MG CAP PHENDIMETRAZINE TARTRATE | $3.3821 per EA | +1.24% |